Shivani Srivastava, PhD
Postdoctoral Associate
Research & Publications
Biography
Locations
Research Interests
Aging; Bone Diseases; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Complications
Selected Publications
- Catalysis-independent ENPP1 protein signaling regulates mammalian bone mass.Zimmerman K, Li X, von Kroge S, Stabach P, Lester ER, Chu EY, Srivastava S, Somerman MJ, Tommasini SM, Busse B, Schinke T, Carpenter TO, Oheim R, Braddock DT. Catalysis-independent ENPP1 protein signaling regulates mammalian bone mass. Journal Of Bone And Mineral Research : The Official Journal Of The American Society For Bone And Mineral Research 2022 PMID: 35773783, DOI: 10.1002/jbmr.4640.
- Anti-oxidant, anti-apoptotic, anti-hypoxic and anti-inflammatory conditions induced by PTY-2 against STZ-induced stress in islets.Srivastava S, Pandey H, Singh SK, Tripathi YB. Anti-oxidant, anti-apoptotic, anti-hypoxic and anti-inflammatory conditions induced by PTY-2 against STZ-induced stress in islets. Bioscience Trends 2019, 13: 382-393. PMID: 31597821, DOI: 10.5582/bst.2019.01181.
- Expression kinetics reveal the self-adaptive role of β cells during the progression of diabetes.Srivastava S, Pandey H, Tripathi YB. Expression kinetics reveal the self-adaptive role of β cells during the progression of diabetes. Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie 2018, 106: 472-482. PMID: 29990835, DOI: 10.1016/j.biopha.2018.06.168.
- Incretin hormones receptor signaling plays the key role in antidiabetic potential of PTY-2 against STZ-induced pancreatitis.Srivastava S, Shree P, Pandey H, Tripathi YB. Incretin hormones receptor signaling plays the key role in antidiabetic potential of PTY-2 against STZ-induced pancreatitis. Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie 2018, 97: 330-338. PMID: 29091882, DOI: 10.1016/j.biopha.2017.10.071.
- Epigenetic Regulation of Gut Microbial Dysbiosis.Srivastava S, Singh A, Sandeep K, Yadav D. Epigenetic Regulation of Gut Microbial Dysbiosis. Indian Journal Of Microbiology 2021, 1-5. PMID: 33612870, PMCID: PMC7877904, DOI: 10.1007/s12088-021-00920-y.
- GLP 1 Regulated Intestinal Cell's Insulin Expression and Selfadaptation before the Onset of Type 2 Diabetes.Srivastava S, Pandey H, Singh SK, Tripathi YB. GLP 1 Regulated Intestinal Cell's Insulin Expression and Selfadaptation before the Onset of Type 2 Diabetes. Advanced Pharmaceutical Bulletin 2019, 9: 325-330. PMID: 31380261, PMCID: PMC6664108, DOI: 10.15171/apb.2019.039.
- Active phytochemicals of Pueraria tuberosa for DPP-IV inhibition: in silico and experimental approach.Srivastava S, Shree P, Tripathi YB. Active phytochemicals of Pueraria tuberosa for DPP-IV inhibition: in silico and experimental approach. Journal Of Diabetes And Metabolic Disorders 2017, 16: 46. PMID: 29201861, PMCID: PMC5697100, DOI: 10.1186/s40200-017-0328-0.
- Gut Microbiome and Metabolic SyndromeSrivastava S, Aditi P, Yadav D. Gut Microbiome and Metabolic Syndrome. The Metabolic Syndrome: Dietary Supplements and Food Ingredients. 2023.
- Beta Cells and DiabetesSrivastava S, Yadav D, Sandeep K, Pandey H, Singh SK, Tripathi YB. Beta Cells and Diabetes. Nutraceuticals and Dietary Supplements: Applications in Health Improvement and Disease Management. 2020 Nov 5:295.
- Pueraria tuberosa as Dipeptidyl-Peptidase-IV Inhibitor Prevents Streptozotocin-Induced Intestinal Stress.Srivastava S, Pandey H, Singh SK, Tripathi YB. Pueraria tuberosa as dipeptidyl-peptidase-IV inhibitor prevents streptozotocin-induced intestinal stress. Open Access Macedonian Journal of Medical Sciences. 2021;9(A):28-34.
- The tuber extract of Pueraria tuberosa linn. competitively inhibits DPP-IV activity in normoglycemic ratsSrivastava S, Koley TK, Singh SK, Tripathi YB. The tuber extract of pueraria tuberosa Linn. competitively inhibits DPP-IV activity in normoglycemic rats. Notes. 2015;20(90):4-9.
- DPP-IV inhibitory potential of methanolic extract of Pueraria tuberosa DC in liver of Alloxan induced diabetic modelSrivastava S, Yadav D, Tripathi YB. DPP-IV inhibitory potential of methanolic extract of Pueraria tuberosa in liver of alloxan induced diabetic model. Biosciences Biotechnology Research Asia. 2018 Mar 25;15(1):01-4.
- Incretin TherapySrivastava S, Yadav D, Pandey H, Tripathi YB. “Chapter 27, Incretin Therapy”. New Perspective in Agriculture and Human Health. Bharti Publications: Delhi, India; 2017.; p.176-185.
- Anti-diabetic Phenolic Compounds of Black Carrot (Daucus carota Subspecies sativus var. atrorubens Alef.) Inhibit Enzymes of Glucose Metabolism: An in silico and in vitro Validation.Karkute SG, Koley TK, Yengkhom BK, Tripathi A, Srivastava S, Maurya A, Singh B. Anti-diabetic Phenolic Compounds of Black Carrot (Daucus carota Subspecies sativus var. atrorubens Alef.) Inhibit Enzymes of Glucose Metabolism: An in silico and in vitro Validation. Medicinal Chemistry (Shariqah (United Arab Emirates)) 2018, 14: 641-649. PMID: 29493459, DOI: 10.2174/1573406414666180301092819.
- Toxicity profile of honey and ghee, when taken together in equal ratio.Aditi P, Srivastava S, Pandey H, Tripathi YB. Toxicity profile of honey and ghee, when taken together in equal ratio. Toxicology Reports 2020, 7: 624-636. PMID: 32455119, PMCID: PMC7235625, DOI: 10.1016/j.toxrep.2020.04.002.
- High-resolution LCMS profiling of phenolic compounds of Indian black carrot and evaluation of its effect on antioxidant defense and glucose metabolism in animal modelKoley TK, Srivastava S, Tripathi YB, Banerjee K, Oulkar D, Goon A, Tripathi A, Singh B. High-resolution LCMS profiling of phenolic compounds of Indian black carrot and evaluation of its effect on antioxidant defense and glucose metabolism in animal model. Agricultural Research. 2019 Dec;8(4):481-9.
- Dendrimers: General Features And ApplicationsYadav D, Sandeep K, Srivastava S, Tripathi YB. Dendrimers: General Features and Applications. InDendrimers for Drug Delivery 2018 Jul 27 (pp. 97-118). Apple Academic Press.
- New Herbal Approaches for the Treatment of Diabetic Kidney Diseases and Its Therapeutic ImplicationsYadav D, Pandey V, Srivastava S, Tripathi YB. New Herbal Approaches for the Treatment of Diabetic Kidney Diseases and Its Therapeutic Implications. InFood Science and Nutrition: Breakthroughs in Research and Practice 2018 (pp. 321-360). IGI Global.